Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis

Free AI-powered analysis and research for Arcutis Biotherapeutics, Inc. stock

Sector: Healthcare

Analyze Arcutis Biotherapeutics, Inc. (ARQT) Stock

Arcutis Biotherapeutics, Inc. (ARQT) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into ARQT stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Arcutis Biotherapeutics, Inc. stock.

Analyze ARQT Now →

📰 Latest Update

Guggenheim Raises Its Price Target on Arcutis Biotherapeutics, Inc. (ARQT) to $35 and Maintains a Buy Rating

Fri, March 6, 2026 at 12:00 PM UTC 3 min read

Guggenheim has raised its price target for Arcutis Biotherapeutics, Inc. (ARQT) to $35 while maintaining a Buy rating. This adjustment reflects confidence in the company's growth potential and pipeline developments, which could enhance investor sentiment and attract new interest in the stock. For investors, this upgrade may signal an opportunity for potential gains as the company continues to progress in the biopharmaceutical sector.

Read full article →